Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
13.34
+0.07 (0.53%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Pharming Group Employees
Pharming Group had 407 employees as of December 31, 2025. The number of employees increased by 3 or 0.74% compared to the previous year.
Employees
407
Change (1Y)
3
Growth (1Y)
0.74%
Revenue / Employee
$907,830
Profits / Employee
$30,361
Market Cap
939.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Kura Oncology | 260 |
| Geron | 258 |
| DBV Technologies | 161 |
| Solid Biosciences | 121 |
| Alpha Tau Medical | 121 |
| Janux Therapeutics | 108 |
| Odyssey Therapeutics | 100 |
PHAR News
- 23 days ago - Pharming Group Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Pharming Group Slides: FY 2026 - Filings
- 23 days ago - Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS - GlobeNewsWire
- 25 days ago - Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 4 weeks ago - Pharming Group announces results of 2026 Annual General Meeting of Shareholders - GlobeNewsWire
- 4 weeks ago - Pharming Group Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Pharming Group Slides: FY 2026 - Filings
- 5 weeks ago - Pharming’s Joenja granted marketing authorization by European Commission - TheFly